SHTDF (SHTDF) Stock Price & Analysis
SHTDF (SHTDF) rose 0.44% to USD 2.3 as of June 10, 2026 at 02:35 UTC, according to Nexqual real-time market data.
SHTDF last closed at USD 2.29; the session ranged USD 2.3–2.3 on volume of 800 shares. Market capitalization is $7.18B, with a 52-week range of USD 2.11–2.7 (PNK). Source: Nexqual, June 10, 2026 at 02:35 UTC.
Key Statistics (as of June 10, 2026 at 02:35 UTC)
| Price | USD 2.3 |
|---|---|
| Change | ▲ 0.44% (up) |
| Previous Close | USD 2.29 |
| Open | USD 2.3 |
| Day Range | USD 2.3 – 2.3 |
| 52-Week Range | USD 2.11 – 2.7 |
| Volume | 800 shares |
| Market Cap | $7.18B |
| Exchange | PNK |
Technical Analysis (SHTDF)
Nexqual's technical model rates SHTDF "SELL" based on 2 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 02:35 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 21.84 (oversold) |
| vs SMA50 | Below (USD 2.46) |
| MACD | -0.04 (negative) |
Analyst Ratings (SHTDF)
Wall Street analysts rate SHTDF "None", per Nexqual as of June 10, 2026 at 02:35 UTC.
| Consensus Rating | None |
|---|
Earnings (SHTDF)
| Next Earnings Date | 2026-04-27 |
|---|
Source: Nexqual, June 10, 2026 at 02:35 UTC.
Financials & Fundamentals (SHTDF)
| Total Revenue | $574.27B |
|---|---|
| Revenue Growth (YoY) | -0.60% |
| Gross Margin | +7.17% |
| Operating Margin | +2.18% |
| Profit Margin | +1.24% |
| ROE | +8.10% |
| Debt / Equity | 55.5 |
| Current Ratio | 1.4 |
| Total Cash | $36.37B |
| Total Debt | $75.76B |
| Free Cash Flow | $-2.77B |
Source: Nexqual, June 10, 2026 at 02:35 UTC.
Financial Health Score (SHTDF)
Nexqual rates SHTDF's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 02:35 UTC.
| Growth | Weak — Revenue -2% YoY (annual), declining |
|---|---|
| Profitability | Weak — Gross margin 7%, operating 2% |
| Balance Sheet | Solid — $36.4B cash vs $75.8B debt |
| Cash Flow | Weak — FCF negative: -$2.77B, burning cash |
| Efficiency | Mixed — ROE 8%, ROA 2.6% |
Ownership (SHTDF)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +68.95% |
| Shares Outstanding | 1.34B |
| Float | 1.34B |
Source: Nexqual, June 10, 2026 at 02:35 UTC.
Leadership (SHTDF)
SHTDF is led by Wanyong Lian (age 54), President & Executive Director, per Nexqual as of June 10, 2026 at 02:35 UTC.
| President & Executive Director | Wanyong Lian (age 54) |
|---|---|
| Executive Director | Binghua Yang (age 45) |
| Chief Financial Officer | Xiaojuan Li (age 49) |
Major Backers & Investors (SHTDF)
Notable institutional backers of SHTDF include Fidelity, LAZARD FUNDS INC-Lazard Emerging Markets Equity Portfolio, Charles Schwab, according to Nexqual as of June 10, 2026 at 02:35 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 4.07% |
| LAZARD FUNDS INC-Lazard Emerging Markets Equity Portfolio | 3.37% |
| Charles Schwab | 0.76% |
| DFA INVESTMENT DIMENSIONS GROUP INC-Emerging Markets Core Eqy. 2 PORT. | 0.69% |
| American Century ETF Trust-Avantis Emerging Markets Equity ETF | 0.59% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.85% |
| BlackRock | 1.02% |
Source: Nexqual, June 10, 2026 at 02:35 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SHTDY | Sinopharm Group Co. Ltd. | USD 10.73 | ▼ 1.38% |
| SHPMY | Shanghai Pharmaceuticals Holdin | USD 7.6 | ▲ 0% |
| SFOSF | SHANGHAI FOSUN PHARMACEUTICAL G | USD 2.6 | ▲ 19.54% |
| CASBF | CANSINO BIOLOGICS INC | USD 3.97 | ▲ 28.06% |
| HLPPY | Hang Lung Properties Ltd. | USD 4.92 | ▼ 1.99% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:35 UTC. This page is informational and not investment advice.